Global phobia treatment market is expected to register brisk growth in the forecast period, 2022-2026 with an impressive CAGR. The market growth can be attributed to the rising instances of anxiety, stress and other mental disorders. The rising geriatric population is more susceptible to mental health issues like phobia of various kinds and thus driving the growth of the global phobia treatment market in the upcoming five years. Moreover, mental health issues rapidly increased during the pandemic. Panic and anxiety caused due to the widespread COVID-19 further surged the demand for effective treatment routine for the phobias and thus aided the growth of the global phobia treatment market in the next five years. Additionally, introduction of technologically advanced therapies and medical devices for the phobia treatment is further substantiating the growth of the global phobia treatment market in the future five years. Vigorous research and device or therapy development is being carried out, the availability of such ailments along with the increased number of market players and anticipated to aid the growth of global phobia treatment market in the forecast years until 2026. Expensive treatment may put a mild restraint on the market growth, although favorable government initiatives along with the favorable insurance policies would support the consumers from availing the treatment practices and confirm the growth of global phobia treatment market in the forecast period.

The global phobia treatment market segmentation is based on type of phobia, treatment, end user, competitional landscape, and regional distribution. Based on type of phobia, the market is further bifurcated into zoophobia, acrophobia, agoraphobia, claustrophobia, social phobia, and others. Zoophobia is the fear of animal/ animals. The person may suffer from the condition due to negative experiences, learned behavior, genetics, or fear processing. Acrophobia is the irrational fear of heights, the person often gets dizzy, or loses balance at heights. In adverse situations, the fear may cause death or cardiac arrest. Agoraphobia is very common in patients suffering from anxiety, panic, and over stressful situation. It is the fear of encountering any place or situation that may cause panic, helplessness, or embarrassment. Similarly, claustrophobia is also an anxiety disorder that causes extreme fear of closed spaces. The patient may get extremely nervous, fearful, and might lose consciousness. Social phobia also known as SAD, is a chronic mental health condition where attempts to conduct social interaction causes anxiety and nervousness. The patient often shows symptoms of embarrassment, self-consciousness, and fear of being rejected by the population.

Some of the market players dominating the global phobia treatment market are Sanofi S.A., Cambrex Corporation, Teva Pharmaceutical Industries Ltd., Midas Pharma GmbH, Harman Finochem Ltd, Pfizer Inc., Dr. Reddy’s Laboratories Ltd, AstraZeneca, Plc., Eli Lily and Company, Lupin Limited, GlaxoSmithKline plc, Aurobindo Pharma Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Bristol Laboratories Ltd, among others. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through phobia treatment. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2016 – 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 – 2026

Objective of the Study:

  • To analyze the historical growth of the market size of global phobia treatment market from 2016 to 2019.
  • To estimate and forecast the market size of global phobia treatment market from 2020 to 2026 and growth rate until 2026. 
  • To classify and forecast global phobia treatment market based on type of phobia, treatment, end user, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the global phobia treatment market.
  • To identify drivers and challenges for global phobia treatment market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global phobia treatment market.
  • To identify and analyze the profile of leading players operating in global phobia treatment market.
  • To identify key sustainable strategies adopted by market players in global phobia treatment market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures and service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global phobia treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, service providers, end users, and other stakeholders
  • Distributors and suppliers of products & services and other stakeholders
  • Organizations, forums, and alliances related to phobia treatment
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, service providers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global phobia treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Phobia Treatment Market, By Type of Phobia:
    • Zoophobia
    • Acrophobia
    • Agoraphobia
    • Claustrophobia
    • Social Phobia
    • Others
  • Global Phobia Treatment Market, By Treatment:
    • Therapy
      • Desensitization
      • Flooding
      • Graded Exposures
      • Biofeedback
    • Medication
      • Antidepressants
      • MAO inhibitors
      • Beta-Blockers
      • Sedative-Hypnotic Drugs
      • Others
  • Global Phobia Treatment Market, By End User:
    • Hospitals
    • Psychiatry Clinics
    • Phobia Treatment Centers
    • Others
  • Global Phobia Treatment Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global phobia treatment market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Phobia Treatment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Phobia Treatment Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Factors Leading to Development of a Phobia

5.2.  Prevalence of Phobia’s, By Gender

5.3.  Prevalence of Phobia’s, By Age

5.4.  Barriers to Phobia Treatment

6.    Global Phobia Treatment Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type of Phobia (Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia, Others)

6.2.2.     By Treatment (Therapy v/s Medication)

6.2.2.1.         By Therapy (Desensitization, Flooding, Graded Exposures, Biofeedback)

6.2.2.2.         By Medication (Antidepressants, MAO inhibitors, Beta-Blockers, Sedative-Hypnotic Drugs, Others)

6.2.3.     By End User (Hospitals, Psychiatry Clinics, Phobia Treatment Centers, Others)

6.2.4.     By Company (2020)

6.2.5.     By Region

6.3.  Product Market Map

7.    North America Phobia Treatment Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type of Phobia (Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia, Others)

7.2.2.     By Treatment (Therapy v/s Medication)

7.2.2.1.         By Therapy (Desensitization, Flooding, Graded Exposures, Biofeedback)

7.2.2.2.         By Medication (Antidepressants, MAO inhibitors, Beta-Blockers, Sedative-Hypnotic Drugs, Others)

7.2.3.     By End User (Hospitals, Psychiatry Clinics, Phobia Treatment Centers, Others)

7.2.4.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Phobia Treatment Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type of Phobia

7.3.1.2.2.             By Treatment

7.3.1.2.3.             By End User

7.3.2.     Mexico Phobia Treatment Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type of Phobia

7.3.2.2.2.             By Treatment

7.3.2.2.3.             By End User

7.3.3.     Canada Phobia Treatment Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type of Phobia

7.3.3.2.2.             By Treatment

7.3.3.2.3.             By End User

8.    Europe Phobia Treatment Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type of Phobia (Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia, Others)

8.2.2.     By Treatment (Therapy v/s Medication)

8.2.2.1.         By Therapy (Desensitization, Flooding, Graded Exposures, Biofeedback)

8.2.2.2.         By Medication (Antidepressants, MAO inhibitors, Beta-Blockers, Sedative-Hypnotic Drugs, Others)

8.2.3.     By End User (Hospitals, Psychiatry Clinics, Phobia Treatment Centers, Others)

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Phobia Treatment Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type of Phobia

8.3.1.2.2.             By Treatment

8.3.1.2.3.             By End User

8.3.2.     Germany Phobia Treatment Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type of Phobia

8.3.2.2.2.             By Treatment

8.3.2.2.3.             By End User

8.3.3.     United Kingdom Phobia Treatment Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type of Phobia

8.3.3.2.2.             By Treatment

8.3.3.2.3.             By End User

8.3.4.     Italy Phobia Treatment Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type of Phobia

8.3.4.2.2.             By Treatment

8.3.4.2.3.             By End User

8.3.5.     Spain Phobia Treatment Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type of Phobia

8.3.5.2.2.             By Treatment

8.3.5.2.3.             By End User

9.    Asia-Pacific Phobia Treatment Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type of Phobia (Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia, Others)

9.2.2.     By Treatment (Therapy v/s Medication)

9.2.2.1.         By Therapy (Desensitization, Flooding, Graded Exposures, Biofeedback)

9.2.2.2.         By Medication (Antidepressants, MAO inhibitors, Beta-Blockers, Sedative-Hypnotic Drugs, Others)

9.2.3.     By End User (Hospitals, Psychiatry Clinics, Phobia Treatment Centers, Others)

9.2.4.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Phobia Treatment Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type of Phobia

9.3.1.2.2.             By Treatment

9.3.1.2.3.             By End User

9.3.2.     India Phobia Treatment Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type of Phobia

9.3.2.2.2.             By Treatment

9.3.2.2.3.             By End User

9.3.3.     Japan Phobia Treatment Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type of Phobia

9.3.3.2.2.             By Treatment

9.3.3.2.3.             By End User

9.3.4.     South Korea Phobia Treatment Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type of Phobia

9.3.4.2.2.             By Treatment

9.3.4.2.3.             By End User

9.3.5.     Australia Phobia Treatment Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type of Phobia

9.3.5.2.2.             By Treatment

9.3.5.2.3.             By End User

10.  South America Phobia Treatment Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type of Phobia (Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia, Others)

10.2.2.  By Treatment (Therapy v/s Medication)

10.2.2.1.      By Therapy (Desensitization, Flooding, Graded Exposures, Biofeedback)

10.2.2.2.      By Medication (Antidepressants, MAO inhibitors, Beta-Blockers, Sedative-Hypnotic Drugs, Others)

10.2.3.  By End User (Hospitals, Psychiatry Clinics, Phobia Treatment Centers, Others)

10.2.4.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Phobia Treatment Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type of Phobia

10.3.1.2.2.           By Treatment

10.3.1.2.3.           By End User

10.3.2.  Argentina Phobia Treatment Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type of Phobia

10.3.2.2.2.           By Treatment

10.3.2.2.3.           By End User

10.3.3.  Colombia Phobia Treatment Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type of Phobia

10.3.3.2.2.           By Treatment

10.3.3.2.3.           By End User

11.  Middle East and Africa Phobia Treatment Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type of Phobia (Zoophobia, Acrophobia, Agoraphobia, Claustrophobia, Social Phobia, Others)

11.2.2.  By Treatment (Therapy v/s Medication)

11.2.2.1.      By Therapy (Desensitization, Flooding, Graded Exposures, Biofeedback)

11.2.2.2.      By Medication (Antidepressants, MAO inhibitors, Beta-Blockers, Sedative-Hypnotic Drugs, Others)

11.2.3.  By End User (Hospitals, Psychiatry Clinics, Phobia Treatment Centers, Others)

11.2.4.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Phobia Treatment Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type of Phobia

11.3.1.2.2.           By Treatment

11.3.1.2.3.           By End User

11.3.2.  Saudi Arabia Phobia Treatment Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type of Phobia

11.3.2.2.2.           By Treatment

11.3.2.2.3.           By End User

11.3.3.  UAE Phobia Treatment Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type of Phobia

11.3.3.2.2.           By Treatment

11.3.3.2.3.           By End User

11.3.4.  Kuwait Phobia Treatment Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Type of Phobia

11.3.4.2.2.           By Treatment

11.3.4.2.3.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Company Profiles (Inclusive of SWOT Analysis of Top 5 Players Profiled)

14.2.1.  Sanofi S.A.

14.2.2.  Cambrex Corporation

14.2.3.  Teva Pharmaceutical Industries Ltd.

14.2.4.  Midas Pharma GmbH

14.2.5.  Harman Finochem Ltd

14.2.6.  Pfizer Inc.

14.2.7.  Dr. Reddy’s Laboratories Ltd

14.2.8.  AstraZeneca, Plc.

14.2.9.  Eli Lily and Company

14.2.10.                Lupin Limited

14.2.11.                GlaxoSmithKline plc

14.2.12.                Aurobindo Pharma Limited

14.2.13.                Sun Pharmaceutical Industries Ltd.

14.2.14.                AbbVie Inc.

14.2.15.                Bristol Laboratories Ltd

15.  Strategic Recommendations

16.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com